Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.56M | -43.21M | 22.37M | 21.50M | 14.44M |
| Total Depreciation and Amortization | 207.00K | 265.00K | 325.00K | 344.00K | 344.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.21M | 15.44M | 15.65M | 8.06M | 7.50M |
| Change in Net Operating Assets | -5.70M | -6.52M | -8.73M | -8.56M | -4.41M |
| Cash from Operations | -32.84M | -34.03M | 29.61M | 21.35M | 17.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 4.00K | 14.00K | 27.00K | 32.00K | 79.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.07M | -33.97M | -44.93M | -14.28M | -20.72M |
| Cash from Investing | 22.08M | -33.95M | -44.91M | -14.25M | -20.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 351.00K | 134.00K | 166.00K | 457.00K | 323.00K |
| Repurchase of Common Stock | -381.00K | -497.00K | -312.00K | -116.00K | -368.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.00K | -363.00K | -146.00K | 341.00K | -45.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.79M | -68.34M | -15.44M | 7.44M | -2.82M |